Abstract: In a puncture needle gripping device that grips a puncture needle that punctures a target in a patient's body and a puncture robot having the puncture needle gripping device, a puncture needle gripping device that can release the puncture needle gripped by the puncture needle gripping device by a remote control, and a puncture robot having the puncture needle gripping device are provided. A puncture needle gripping device includes a first finger and a second finger that pinches a proximal end of a puncture needle therebetween, and a releasing mechanism that grips the puncture needle by pinching the proximal end of the puncture needle between the first finger and the second finger and releases the puncture needle by separating the first finger and the second finger from each other by remote control.

Abstract: To provide a method for determining the sensitivity of a patient to irinotecan, SN-38, and/or a salt thereof, which method can determine the therapeutic response of the patient and to provide a novel cancer therapeutic means employing the method. The method for determining the sensitivity of a subject to irinotecan, SN-38, and/or a salt thereof includes measuring the expression levels of AMD1 gene, CTSC gene, EIF1AX gene, C12orf30 gene, DDX54 gene, PTPN2 gene, and TBX3 gene in a specimen, and calculating the best tumor response rate (%), overall survival (days), or progression-free survival (days) from formulas (1) to (3).

Abstract: To provide a method for determining the sensitivity of a patient to irinotecan, SN-38, and/or a salt thereof, which method can determine the therapeutic response of the patient and to provide a novel cancer therapeutic means employing the method. The method for determining the sensitivity of a subject to irinotecan, SN-38, and/or a salt thereof includes measuring the expression levels of AMD1 gene, CTSC gene, EIF1AX gene, C12orf30 gene, DDX54 gene, PTPN2 gene, and TBX3 gene in a specimen, and calculating the best tumor response rate (%), overall survival (days), or progression-free survival (days) from formulas (1) to (3).

Abstract: It can be enabled an accurate diagnosis of osteoporosis by a simple method utilizing panoramic radiographs without requiring special skill or experience of a technician engaged in diagnosis of osteoporosis.

Abstract: The present invention provides a gene related to cancer cell immortalization (an immortalization determining gene) and a process that is useful for selective cancer treatment targeting a cancer cell having the gene. The present invention determines an immortalized cancer cell using a polynucleotide having a base sequence of at least 15 bases that specifically hybridizes with a continuous base sequence of at least 15 bases within any one of abase sequences represented by SEQ ID Nos. 1 to 13. In the foregoing process, the polynucleotide is used as a primer or probe for detecting an immortalization determining gene that exhibits high expression specifically in an immortalized cancer cell.